CGN Advisors LLC’s holdings in Eli Lilly and Company were worth $2,736,000 as of its most recent SEC filing. WestEnd Advisors LLC boosted its position in shares of Eli Lilly and Company by 210.0% during the first quarter. Wealth Preservation Advisors LLC acquired a new position in shares of Eli Lilly and Company during the first quarter worth approximately $27,000. Read Our Latest Analysis on Eli Lilly and CompanyEli Lilly and Company Profile(Free Report)Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and Company and related companies with MarketBeat.com's FREE daily email newsletter.